<?xml version="1.0" encoding="UTF-8"?>
<p>With the emergence of new viral strains and increasing resistance to standard antiviral therapy, and the fact that most of the available antiviral therapies are non-specific for particular viruses [
 <xref rid="B8-biomolecules-11-00042" ref-type="bibr">8</xref>], the key focus of medical research is therefore centered on the development of specific and cost-effective antiviral regimens [
 <xref rid="B9-biomolecules-11-00042" ref-type="bibr">9</xref>,
 <xref rid="B10-biomolecules-11-00042" ref-type="bibr">10</xref>], which include alternative treatment from herbal sources. At present, several antiviral vaccinations are available including human papilloma virus [
 <xref rid="B11-biomolecules-11-00042" ref-type="bibr">11</xref>], hepatitis A and B virus [
 <xref rid="B12-biomolecules-11-00042" ref-type="bibr">12</xref>], varicella, measles, mumps, rubella [
 <xref rid="B13-biomolecules-11-00042" ref-type="bibr">13</xref>], and rabies [
 <xref rid="B14-biomolecules-11-00042" ref-type="bibr">14</xref>]. However, there are still no vaccines for a few other viral infections.
</p>
